Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-30

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is divided into two parts:

Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors.

Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gastric Cancer Risk Factors Associated With EU and CELAC Populations

NCT03957031

Cancer, Gastric

COMPLETED

Volatile Markers in Digestive Cancer

NCT02332213

Colorectal Cancer Colorectal Adenoma Gastric Cancer +6 more

COMPLETED

Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations

NCT01803750

For New York State Registered Family Practitioners and Internal Medicine Physicians

TERMINATED

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

NCT06370143

Gastric Atrophy Gastric Intestinal Metaplasia Dysplasia +2 more

RECRUITING

Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma

NCT02947607

Colorectal Adenoma and Carcinoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Part 1: to determinate the grade of knowledge of established GC risk factors and identification of attitudes about, GC screening programs at baseline, prior to the intervention though an educational program.

Part 2: to generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at 6th, 12th, 24th and at Month 36th.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects \>18 years old, from EU and CELAC countries participating in this study.

* Subjects ≥18 years old diagnose from H. pylori infection and treated at participant sites

Exclusion Criteria

* Subjects who have received some prior preparation (Cancer Gastric Information).
* Subjects who have previous Knowledge in Gastric Cancer (Example, near relatives who have suffered Gastric Cancer

* Subjects with chronic gastritis without confirmed diagnose of H. pylori infection, pathologically of by urease test.
* Patient's with CG diagnosis (including gastroesophageal junction cancer).

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No